1. Home
  2. TMDX vs COLD Comparison

TMDX vs COLD Comparison

Compare TMDX & COLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • COLD
  • Stock Information
  • Founded
  • TMDX 1998
  • COLD 1903
  • Country
  • TMDX United States
  • COLD United States
  • Employees
  • TMDX N/A
  • COLD N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • COLD Real Estate Investment Trusts
  • Sector
  • TMDX Health Care
  • COLD Real Estate
  • Exchange
  • TMDX Nasdaq
  • COLD Nasdaq
  • Market Cap
  • TMDX 3.9B
  • COLD 3.8B
  • IPO Year
  • TMDX 2019
  • COLD 2018
  • Fundamental
  • Price
  • TMDX $115.69
  • COLD $12.99
  • Analyst Decision
  • TMDX Buy
  • COLD Buy
  • Analyst Count
  • TMDX 11
  • COLD 14
  • Target Price
  • TMDX $125.40
  • COLD $19.64
  • AVG Volume (30 Days)
  • TMDX 958.8K
  • COLD 6.7M
  • Earning Date
  • TMDX 10-27-2025
  • COLD 11-06-2025
  • Dividend Yield
  • TMDX N/A
  • COLD 7.08%
  • EPS Growth
  • TMDX 2163.11
  • COLD N/A
  • EPS
  • TMDX 2.02
  • COLD N/A
  • Revenue
  • TMDX $531,292,000.00
  • COLD $2,616,917,000.00
  • Revenue This Year
  • TMDX $38.87
  • COLD N/A
  • Revenue Next Year
  • TMDX $20.70
  • COLD $3.72
  • P/E Ratio
  • TMDX $57.33
  • COLD N/A
  • Revenue Growth
  • TMDX 48.09
  • COLD N/A
  • 52 Week Low
  • TMDX $55.00
  • COLD $11.90
  • 52 Week High
  • TMDX $146.98
  • COLD $27.68
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 49.53
  • COLD 45.87
  • Support Level
  • TMDX $109.77
  • COLD $12.05
  • Resistance Level
  • TMDX $115.90
  • COLD $12.55
  • Average True Range (ATR)
  • TMDX 4.84
  • COLD 0.43
  • MACD
  • TMDX -0.12
  • COLD 0.06
  • Stochastic Oscillator
  • TMDX 31.21
  • COLD 52.16

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About COLD Americold Realty Trust Inc.

Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 239 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.

Share on Social Networks: